24 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

RVU

Ryvu Therapeutics
zł59.00-1.5%-5.3%zł1.4bzł71.88PS20.3xE-11.9%n/a

SLV

Selvita
zł61.502.0%-27.5%zł1.1bzł71.58PE46.3xE32.7%n/a

CLN

Celon Pharma
zł15.301.6%2.3%zł781.2mzł16.88PS3.6xE59.5%0.6%

BCX

Bioceltix
zł89.00-1.8%113.4%zł367.5mn/aPB25.8xn/an/a

MOC

Molecure
zł18.300.5%-18.3%zł308.1mzł34.00PS223.9xE-6.3%n/a

BIO

BIOTON
zł3.58-0.7%4.5%zł307.0mn/aPE161.7xn/an/a

CTX

Captor Therapeutics Spolka Akcyjna
zł65.60-18.2%-54.3%zł304.8mzł115.00PS24.3xE109.8%n/a

SVE

Synthaverse
zł4.112.0%-29.7%zł289.8mn/aPE83.7xn/an/a

MAB

Mabion
zł16.24-2.6%-10.8%zł262.5mzł15.57PE4.5xE-15.5%n/a

PTG

Poltreg
zł54.402.3%1.5%zł253.7mzł55.00PS169.2xE11.2%n/a

URT

Urteste
zł97.00-3.0%-37.8%zł136.7mn/an/an/an/a

GMT

Genomtec
zł10.65-4.1%8.0%zł130.5mn/aPS6870.9xn/an/a

BGD

Biogened
zł30.4016.9%132.1%zł74.7mn/aPE17.8xn/a1.3%

MDB

Medicofarma Biotech
zł0.971.9%-12.6%zł66.2mn/aPS88.2xn/an/a

RDG

Read-Gene
zł5.20-2.8%53.4%zł61.3mn/aPS6.1xn/an/a

GEN

Genomed Spólka Akcyjna
zł29.600.7%-22.1%zł39.1mn/aPE39.4xn/a0%

CBD

Cannabis Poland
zł0.55-8.6%51.3%zł27.2mn/aPS415.1xn/an/a

PUR

Pure Biologics
zł8.12-11.7%-54.8%zł27.0mn/aPS247.9xn/an/a

GX1

genXone
zł8.008.4%-11.0%zł26.4mn/aPS11xn/a0%

SCS

Stem Cells Spin
zł0.5816.0%52.6%zł24.0mn/aPS57.2xn/an/a

NNG

NanoGroup
zł0.941.9%-24.8%zł19.0mn/aPB2.6xn/an/a

BER

Bioerg Spólka Akcyjna
zł0.140%-17.6%zł13.8mn/aPS46.1xn/an/a

IGN

Inno-Gene
zł1.99-17.1%-63.8%zł11.3mn/aPS10.1xn/an/a

LCN

Labocanna
zł0.47-3.1%-2.0%zł10.0mn/aPS603.1xn/an/a
Page 1 of 1
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.